HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's disease.

Abstract
The clinical effects and pharmacokinetic profiles of single doses of Madopar HBS were compared with those of standard Madopar in two studies in patients with Parkinson's disease and 'on-off' fluctuations. In the first study, 10 fasting patients received equivalent doses (200 mg levodopa plus 50 mg benserazide) of each preparation. The clinical response to Madopar HBS was delayed and brief; the relative bioavailability was only 50%. In the second study in 7 non-fasted patients, the effects of 3 capsules of Madopar HBS 125 were compared with those of 2 capsules of standard Madopar 125. Delay to turn on was longer with HBS, but duration of time on, and delay to turn off, were longer with this preparation. The area under the concentration-time curve for plasma levodopa was greater with HBS, and the maximum levodopa concentration was similar to, but achieved later than standard Madopar.
AuthorsM H Marion, F Stocchi, S L Malcolm, N P Quinn, P Jenner, C D Marsden
JournalEuropean neurology (Eur Neurol) Vol. 27 Suppl 1 Pg. 54-8 ( 1987) ISSN: 0014-3022 [Print] Switzerland
PMID3322837 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Delayed-Action Preparations
  • Drug Combinations
  • Hydrazines
  • benserazide, levodopa drug combination
  • Levodopa
  • Benserazide
Topics
  • Administration, Oral
  • Adult
  • Aged
  • Benserazide (administration & dosage, pharmacokinetics, therapeutic use)
  • Biological Availability
  • Clinical Trials as Topic
  • Delayed-Action Preparations
  • Drug Combinations (pharmacokinetics, therapeutic use)
  • Humans
  • Hydrazines (therapeutic use)
  • Levodopa (administration & dosage, pharmacokinetics, therapeutic use)
  • Middle Aged
  • Parkinson Disease (drug therapy)
  • Random Allocation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: